Amanda Deligtisch

1.3k total citations
15 papers, 401 citations indexed

About

Amanda Deligtisch is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Amanda Deligtisch has authored 15 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Psychiatry and Mental health. Recurrent topics in Amanda Deligtisch's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Amanda Deligtisch is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Amanda Deligtisch collaborates with scholars based in United States and Netherlands. Amanda Deligtisch's co-authors include Susan Bressman, Connie Marras, Sarah A. Jewell, Cheryl Meng, Grace S. Bhudhikanok, G. Webster Ross, Kelly E. Lyons, Joseph Jankovic, J. William Langston and Robert D. Abbott and has published in prestigious journals such as Neurology, Journal of Cerebral Blood Flow & Metabolism and Human Brain Mapping.

In The Last Decade

Amanda Deligtisch

13 papers receiving 387 citations

Peers

Countries citing papers authored by Amanda Deligtisch

Since Specialization

Citations

This map shows the geographic impact of Amanda Deligtisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Deligtisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Deligtisch more than expected).

Fields of papers citing papers by Amanda Deligtisch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Deligtisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Deligtisch. The network helps show where Amanda Deligtisch may publish in the future.

Co-authorship network of co-authors of Amanda Deligtisch

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Deligtisch. A scholar is included among the top collaborators of Amanda Deligtisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Deligtisch. Amanda Deligtisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The influence of intermittent hypercapnia on cerebrospinal fluid flow and clearance in Parkinson’s disease and healthy older adults 2025 ·npj Parkinson s Disease ·Erik B. Erhardt, Andrew R. Mayer, Henry C. Lin, (unknown), Nicholas A. Shaff, Andrei A. Vakhtin, Arvind Caprihan, Harm J. van der Horn, Natalie Hoffman, J. P. Phillips, Madeleine Grigg‐Damberger, C Wang, J. Gough, (unknown), Amanda Deligtisch, (unknown), (unknown), Sephira G. Ryman	1
2	Parkinson’s disease cerebrovascular reactivity pattern: A feasibility study 2024 ·Journal of Cerebral Blood Flow & Metabolism ·Harm J. van der Horn, Andrei A. Vakhtin, (unknown), (unknown), (unknown), Andrew B. Dodd, Erik B. Erhardt, J. P. Phillips, Sarah Pirio Richardson, Amanda Deligtisch, Melanie Stewart, (unknown), Sanne K. Meles, Andrew R. Mayer, Sephira G. Ryman	9
3	Comparison of automated and manual quantification methods for neuromelanin‐sensitive MRI in Parkinson's disease 2023 ·Human Brain Mapping ·(unknown), Erik B. Erhardt, (unknown), (unknown), Christopher J. Wertz, Andrei A. Vakhtin, Arvind Caprihan, (unknown), Amanda Deligtisch, Sarah Pirio Richardson, Andrew R. Mayer, Sephira G. Ryman	3
4	Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease 2023 ·Movement Disorders ·Sephira G. Ryman, (unknown), Andrew B. Dodd, (unknown), Christopher J. Wertz, (unknown), (unknown), Amanda Deligtisch, Erik B. Erhardt, Henry C. Lin, Andrei A. Vakhtin, Kathleen L. Poston, Rawan Tarawneh, Sarah Pirio Richardson, Andrew R. Mayer	9
5	4 Compensatory Functional Activation During Motion Discrimination in Parkinson’s Disease 2023 ·Journal of the International Neuropsychological Society ·(unknown), (unknown), (unknown), David B. Stone, Andrei A. Vakhtin, Andrew R. Mayer, Elena K. Festa, William C. Heindel, David P. Salmon, (unknown), Amanda Deligtisch, Sarah Pirio Richardson, Sephira G. Ryman	0
6	Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease 2023 ·Clinical Parkinsonism & Related Disorders ·Erik B. Erhardt, (unknown), (unknown), (unknown), (unknown), Andrei A. Vakhtin, Andrew R. Mayer, John C. Adair, Janice E. Knoefel, Gary A. Rosenberg, Kathleen L. Poston, (unknown), Amanda Deligtisch, Sarah Pirio Richardson, Sephira G. Ryman	2
7	Preoperative frailty risk in deep brain stimulation patients: Risk analysis index predicts Clavien-Dindo IV complications 2023 ·Clinical Neurology and Neurosurgery ·Oluwafemi P. Owodunni, Katie Roster, (unknown), Syed Faraz Kazim, (unknown), Omar H. Tarawneh, Rachel Thommen, (unknown), Jason P. Sheehan, Rohini McKee, Amanda Deligtisch, Meic H. Schmidt, Christian A. Bowers	16
8	A Case of Delayed Post-Hypoxic Leukoencephalopathy Masquerading as a Primary Psychiatric Disorder (P1.155) 2017 ·Neurology ·Dinesh Jillella, (unknown), Amanda Deligtisch	1
9	Dystonia Treatment: A Survey of Medication Use in an International Biorepository (P2.353) 2016 ·Neurology ·Sarah Pirio Richardson, (unknown), Betty Skipper, Amanda Deligtisch	1
10	Differential Diagnosis of Psychiatric Symptoms After Deep Brain Stimulation for Movement Disorders 2014 ·Neuromodulation Technology at the Neural Interface ·Davin K. Quinn, Amanda Deligtisch, (unknown), (unknown), (unknown), (unknown), Chris Abbott	2
11	Catatonia After Deep Brain Stimulation Successfully Treated With Lorazepam and Right Unilateral Electroconvulsive Therapy 2013 ·Journal of Ect ·Davin K. Quinn, (unknown), (unknown), Amanda Deligtisch, (unknown), (unknown), Chris Abbott	9
12	Occupation and risk of parkinsonism: a multicenter case-control study. 2009 ·PubMed ·Caroline M. Tanner, G. Webster Ross, Sarah A. Jewell, Robert A. Hauser, Joseph Jankovic, Stewart A. Factor, Susan Bressman, Amanda Deligtisch, Connie Marras, Kelly E. Lyons, Grace S. Bhudhikanok, (unknown), Cheryl Meng, Robert D. Abbott, J. William Langston	194
13	Occupation and Risk of Parkinsonism 2009 ·Archives of Neurology ·Caroline M. Tanner, G. Webster Ross, Sarah A. Jewell, Robert A. Hauser, Joseph Jankovic, Stewart A. Factor, Susan Bressman, Amanda Deligtisch, Connie Marras, Kelly E. Lyons, Grace S. Bhudhikanok, (unknown), Cheryl Meng, Robert D. Abbott, (unknown)	0
14	Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish–Mennonites 2007 ·American Journal of Medical Genetics Part A ·Rachel Saunders‐Pullman, Deborah Raymond, Geetha Senthil, Patricia Kramer, Erin Ohmann, Amanda Deligtisch, Vicki Shanker, Paul Greene, (unknown), Neng Huang, Michele Tagliati, Patricia L. Kavanagh, Jeannie Soto‐Valencia, Patrícia de Carvalho Aguiar, Neil Risch, Laurie J. Ozelius, Susan Bressman	48
15	Validity of spiral analysis in early Parkinson's disease 2007 ·Movement Disorders ·Rachel Saunders‐Pullman, Carol A. Derby, Kaili Stanley, A Floyd, Susan Bressman, Richard B. Lipton, Amanda Deligtisch, Lawrence Severt, Qiping Yu, Mónica Kurtis, Seth L. Pullman	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact